Evidence map›Paper›PMID 34824846›Full record

ArticleClinical case reports2021

Priapism as the first manifestation in chronic myeloid leukemia: A case report and focused review of literature.

Claudia Lucia Sossa Melo, Carlos Alberto Orozco Orozco, Angela Maria Peña Castellanos, Maria Alejandra Rueda Perea, Cristian Orlando Porras Bueno, Carlos Ivan Romero Diaz, Helga Natalia Rojas Rodríguez

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Claudia Lucia Sossa MeloServicio de Hemato-oncología Fundación Oftalmológica de Santander Facultad Ciencias de la Salud Universidad Autónoma de Bucaramanga Bucaramanga Colombia.ORCID https://orcid.org/0000-0001-9876-222X
Carlos Alberto Orozco OrozcoServicio de Hemato-oncología Fundación Oftalmológica de Santander Programa para el Tratamiento y Estudio de Enfermedades Hematológicas y Oncológicas de Santander - PROTEHOS Bucaramanga Colombia.ORCID https://orcid.org/0000-0001-7858-0525
Angela Maria Peña CastellanosServicio de Hemato-oncología Fundación Oftalmológica de Santander Programa para el Tratamiento y Estudio de Enfermedades Hematológicas y Oncológicas de Santander - PROTEHOS Bucaramanga Colombia.
Maria Alejandra Rueda PereaFacultad Ciencias de la Salud Universidad Autónoma de Bucaramanga Bucaramanga Colombia.
Cristian Orlando Porras BuenoFacultad Ciencias de la Salud Universidad Autónoma de Bucaramanga Bucaramanga Colombia.ORCID https://orcid.org/0000-0001-9618-0744
Carlos Ivan Romero DiazFacultad Ciencias de la Salud Universidad Autónoma de Bucaramanga Bucaramanga Colombia.ORCID https://orcid.org/0000-0002-8881-1400
Helga Natalia Rojas RodríguezFacultad Ciencias de la Salud Universidad Autónoma de Bucaramanga Bucaramanga Colombia.
Universidad Autónoma de Bucaramanga · COFoscal Hospital · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the case of a patient who was initially presented with ischemic priapism to the emergency department. He was treated with adrenaline intracavernous injections and aspiration with irrigation of the corpora cavernosa and distal shunt. In the postoperative period, anemia, basophilia, eosinophilia, thrombocytosis and hyperleukocytosis were detected. The patient was subsequently diagnosed with chronic myeloid leukemia. Priapism is a rare manifestation of chronic myeloid leukemia (≤ 3%) and occurs mostly due to hyperleukocytosis, resulting in thrombus formation and corporal venous outflow obstruction. Priapism occurring in any setting is considered as a medical emergency that requires immediate local therapy because of resulting irreversible cell damage and fibrosis if not treated within the first 24-48 h.

Indexed as

BCR‐ABL positivecase reportschronicerectile dysfunctionleukemiamyelogenouspriapism

Identifiers

PMID34824846
PMCPMC8603417
OpenAlexW3216574735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.